We are live on ! Find out more
HCA icon

HCA Healthcare

448 hedge funds and large institutions have $19.2B invested in HCA Healthcare in 2014 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 182 increasing their positions, 148 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

128% more first-time investments, than exits

New positions opened: 73 | Existing positions closed: 32

23% more repeat investments, than reductions

Existing positions increased: 182 | Existing positions reduced: 148

10% more funds holding

Funds holding: 409448 (+39)

9% more funds holding in top 10

Funds holding in top 10: 3235 (+3)

4% more capital invested

Capital invested by funds: $18.3B → $19.2B (+$818M)

0.16% less ownership

Funds ownership: 76.79%76.64% (-0.16%)

32% less call options, than puts

Call options by funds: $153M | Put options by funds: $224M

Holders
448
Holders Change
+39
Holders Change %
+9.54%
% of All Funds
12.88%
Holding in Top 10
35
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+9.38%
% of All Funds
1.01%
New
73
Increased
182
Reduced
148
Closed
32
Calls
$153M
Puts
$224M
Net Calls
-$71.9M
Net Calls Change
-$62.4M
Name Holding Trade Value Shares
Change
Change in
Stake
Parallax Volatility Advisers
301
Parallax Volatility Advisers
California
$1.25M -$114K -2,164 -9%
RFS
302
Rockefeller Financial Services
New York
$1.22M
CA
303
Commerzbank Aktiengesellschaft
Germany
$1.22M +$260K +4,927 +29%
ProShare Advisors
304
ProShare Advisors
Maryland
$1.2M +$144K +2,722 +15%
WBC
305
Westpac Banking Corp
Australia
$1.19M -$18.8K -356 -2%
MAM
306
Mizuho Asset Management
Japan
$1.15M -$16.9K -320 -2%
NCCM
307
Nine Chapters Capital Management
New Jersey
$1.14M -$1.02M -19,400 -49%
MYLI
308
Meiji Yasuda Life Insurance
Japan
$1.14M +$522K +9,900 +96%
LC
309
Loews Corp
New York
$1.13M
ACM
310
Argonaut Capital Management
New York
$1.13M +$1.06M +20,000 New
SCM
311
Sandler Capital Management
New York
$1.13M +$1.06M +20,000 New
Nisa Investment Advisors
312
Nisa Investment Advisors
Missouri
$1.11M -$56.5K -1,070 -5%
BF
313
BOK Financial
Oklahoma
$1.1M +$1.69K +32 +0.2%
SMG
314
Spectrum Management Group
Indiana
$1.09M +$19K +360 +2%
CPIM
315
Columbia Partners Investment Management
Virginia
$1.08M +$1.02M +19,252 New
CIBC Asset Management
316
CIBC Asset Management
Ontario, Canada
$1.08M -$4.85K -92 -0.5%
WAM
317
World Asset Management
Michigan
$1.08M -$5.49K -104 -0.5%
US Bancorp
318
US Bancorp
Minnesota
$1.02M +$302K +5,722 +46%
VFP
319
Verus Financial Partners
Virginia
$1.02M
SLI
320
Sumitomo Life Insurance
Japan
$1.01M +$120K +2,279 +15%
KT
321
Kanaly Trust
Texas
$1M -$31.6K -598 -3%
Susquehanna International Group
322
Susquehanna International Group
Pennsylvania
$997K +$583K +11,059 +167%
HNB
323
Huntington National Bank
Ohio
$978K +$411K +7,799 +82%
MOACM
324
Mutual of America Capital Management
New York
$953K +$64.3K +1,219 +8%
BWAM
325
Boyd Watterson Asset Management
Ohio
$949K -$67.8K -1,286 -7%

HCA Hedge Fund Activity: Q2 2014 in Review

448 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q2 2014, worth a combined $19.2B — up 4.5% from $18.3B a quarter earlier.

Buyers outnumbered sellers: 73 funds opened new HCA positions and 32 closed out — a net gain of 41 holders — while 182 added to existing stakes and 148 trimmed.

The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $156M. The largest seller was Bain Capital Investors, cutting an estimated $780M.

  • 448 institutional investors held HCA Healthcare (HCA) as of Q2 2014, up from 409 in Q1 2014.
  • Funds reported $19.2B of HCA Healthcare stock for Q2 2014, up 4.5% quarter-over-quarter.
  • 73 funds opened new HCA Healthcare positions in Q2 2014 and 32 closed out, a net change of +41 holders.
  • The largest HCA Healthcare buyer in Q2 2014 was First Eagle Investment Management, an estimated $156M added.
  • The largest HCA Healthcare seller in Q2 2014 was Bain Capital Investors, an estimated $780M sold.

Based on aggregated 13F filings for Q2 2014.